Change in substantial holding
Released
Released
Announcement PDF
604
Page 1 of 3
Form 604
Corporations Act 2001
Section 671B
Notice of change of interests of substantial holder
To Company Name/Scheme
Radiopharm Theranostics Ltd
ACN/ARSN/ABN
57 647 877 889
1. Details of substantial holder (1)
Name
JPMorgan Chase & Co. and its affiliates
ACN/ARSN (if applicable)
NA
There was a change in the interests of the
substantial holder on
21/January/2025
The previous notice was given to the company on
29/August/2024
DD/MMM/YYYY
The previous notice was dated
27/August/2024
2. Previous and present voting power
The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an
associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or
scheme, are as follows:
Class of securities (4)
Previous notice
Person’s votes
Ordinary
177,585,973
Present notice
Voting power (5)
8.54%
Person’s votes
174,583,414
Voting power (5)
7.48%
3. Changes in relevant interests
Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the
company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:
Date of
change
Person whose relevant interest Nature of change (6)
changed
Consideration given Class and number of Person's
in relation to
securities affected
votes
change (7)
affected
See Appendix
J.P. MORGAN SECURITIES
LLC
Holder of securities subject to an obligation to
return under a securities lending agreement
See Appendix
5,100,000
(Ordinary)
5,100,000
(Ordinary)
See Appendix
J.P. MORGAN SECURITIES
LLC
Rehypothecation of client securities under a
Prime Brokerage Agreement
See Appendix
1,912,200
(Ordinary)
1,912,200
(Ordinary)
See Appendix
J.P. MORGAN SECURITIES
AUSTRALIA LIMITED
Purchase and sales of securities in its capacity
as Principal/Proprietary
See Appendix
10,014,759
(Ordinary)
10,014,759
(Ordinary)
604
Page 2 of 3
4. Present relevant interests
Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows:
Holder of relevant interest
Registered holder of
securities
Person entitled
to be registered
as holder (8)
Nature of relevant interest (6)
Class and
number of
securities
Person's
votes
J.P. MORGAN
SECURITIES LLC
Citi Australia
Various Clients
and Custodians
Rehypothecation of client
securities under a Prime
Brokerage Agreement
1,912,200
(Ordinary)
1,912,200
(Ordinary)
J.P. MORGAN
SECURITIES LLC
Citi Australia
Citi Australia
Holder of securities subject to
an obligation to return under a
securities lending agreement
5,100,000
(Ordinary)
5,100,000
(Ordinary)
J.P. MORGAN
SECURITIES AUSTRALIA
LIMITED
Ecapital Nominees Pty
Ltd
J.P. MORGAN
SECURITIES
AUSTRALIA
LIMITED
Purchase and sales of
securities in its capacity as
Principal/Proprietary
167,571,214
(Ordinary)
167,571,214
(Ordinary)
5. Changes in association
The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the
substantial holder in relation to voting interests in the company or scheme are as follows:
Name and ACN/ARSN (if applicable)
Nature of association
J.P. MORGAN SECURITIES AUSTRALIA LIMITED
Subsidiary of JPMorgan Chase & Co.
J.P. MORGAN SECURITIES LLC
Subsidiary of JPMorgan Chase & Co.
6. Addresses
The addresses of persons named in this form are as follows:
Name
Address
JPMorgan Chase & Co.
J.P. MORGAN SECURITIES AUSTRALIA LIMITED
J.P. MORGAN SECURITIES LLC
383 Madison Avenue, New York, New York, NY, 10179, United States
LEVEL 18, 83-85 CASTLEREAGH STREET, SYDNEY, NSW 2000, Australia
383 Madison Ave., New York, New York, NY, 10179, United States
Signature
print name
sign here
S. Seshagiri Rao
Capacity
Compliance Officer
Date
23/January/2025
604
Page 3 of 3
DIRECTIONS
(1)
If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the
manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of
persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group,
with the names and addresses of members is clearly set out in paragraph 6 of the form.
(2)
See the definition of "associate" in section 9 of the Corporations Act 2001.
(3)
See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
(4)
The voting shares of a company constitute one class unless divided into separate classes.
(5)
The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.
(6)
Include details of:
(a)
any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4)
applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and
accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this
contract, scheme or arrangement; and
(b)
any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or
disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification
applies).
See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.
(7)
Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired
has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the
happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation
to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.
(8)
If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write
"unknown".
(9)
Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.
TRADES FOR RELEVANT PERIOD
Transaction Date
Balance at start of relevant period
30-Sep-24
30-Sep-24
23-Oct-24
25-Oct-24
28-Oct-24
29-Oct-24
6-Dec-24
10-Dec-24
12-Dec-24
16-Dec-24
20-Dec-24
24-Dec-24
26-Dec-24
27-Dec-24
3-Jan-25
3-Jan-25
6-Jan-25
6-Jan-25
6-Jan-25
6-Jan-25
7-Jan-25
7-Jan-25
7-Jan-25
9-Jan-25
9-Jan-25
9-Jan-25
13-Jan-25
13-Jan-25
13-Jan-25
13-Jan-25
13-Jan-25
13-Jan-25
14-Jan-25
14-Jan-25
14-Jan-25
14-Jan-25
15-Jan-25
15-Jan-25
15-Jan-25
15-Jan-25
16-Jan-25
16-Jan-25
16-Jan-25
16-Jan-25
16-Jan-25
17-Jan-25
21-Jan-25
21-Jan-25
21-Jan-25
21-Jan-25
21-Jan-25
Balance at end of relevant period
Appendix
Entity
Product Type
Type of Transaction
J.P. MORGAN SECURITIES AUSTRALIA LIMITED
J.P. MORGAN SECURITIES AUSTRALIA LIMITED
J.P. MORGAN SECURITIES AUSTRALIA LIMITED
J.P. MORGAN SECURITIES AUSTRALIA LIMITED
J.P. MORGAN SECURITIES AUSTRALIA LIMITED
J.P. MORGAN SECURITIES AUSTRALIA LIMITED
J.P. MORGAN SECURITIES AUSTRALIA LIMITED
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
J.P. MORGAN SECURITIES LLC
Equity
Equity
Equity
Equity
Equity
Equity
Equity
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Depository Receipt
Buy
Sell
Sell
Sell
Sell
Sell
Sell
Borrow
Borrow Return
Borrow Return
Borrow
Borrow
Borrow Return
Borrow Return
Borrow
Borrow
Borrow
Borrow Return
Borrow Return
Borrow Return
Borrow
Borrow
Borrow
Borrow
Borrow Return
Borrow
Borrow
Borrow
Borrow
Borrow
Borrow
Borrow
Borrow
Borrow
Borrow
Borrow
Borrow
Borrow
Borrow
Borrow
Borrow Return
Borrow Return
Borrow Return
Borrow Return
Borrow
Borrow
Borrow
Borrow Return
Borrow Return
Borrow
On-Lend
Quantity
177,585,973
75,545,720
(75,545,720)
(5,308)
(616)
(7,701)
(1,134)
(10,000,000)
90,000
(60,000)
(30,000)
60,000
30,000
(30,000)
(60,000)
90,000
90,000
60,000
(30,000)
(60,000)
(60,000)
30,000
30,000
90,000
60,000
(60,000)
60,000
300,000
330,000
2,100,000
120,000
60,000
960,000
90,000
30,000
30,000
30,000
60,000
240,000
240,000
60,000
(300,000)
(120,000)
(30,000)
(30,000)
30,000
90,000
750,000
(240,000)
(30,000)
30,000
1,912,200
174,583,414
Price (AUD)
0.03
0.03
0.03
0.03
0.03
0.03
0.03
-
Consideration
2,266,371.60
2,266,371.60
148.62
16.94
200.23
28.92
280,000.00
-
1/1
Appendix: Prescribed information pursuant to securities lending transaction disclosed under the substantial
shareholding notice filed with ASX.
Date:
Company’s name:
ISIN:
Date of change of
relevant interests:
Schedule
Type of agreement
23-Jan-2025
RADIOPHARM THERANOSTICS LTD
AU0000181851
21-Jan-2025
Institutional Account Agreement
JP Morgan Securities LLC for itself and as agent and trustee for the other J.P. Morgan Entities and
APEX CLEARING CORPORATION, CHARLES SCHWAB & CO., INC, FUTU CLEARING INC,
INTERACTIVE BROKERS LLC, MORGAN STANLEY & CO LLC, NATIONAL FINANCIAL
SERVICES LLC, ROBINHOOD SECURITIES, LLC, TRADESTATION SECURITIES INC and
VELOCITY CLEARING, LLC (herein referred to as “JPMS”).
Parties to agreement
“ J.P. Morgan Entities” means, as the context may require or permit, any and all of JPMSL, JPMorgan
Chase Bank, N.A., J.P. Morgan Securities LLC., J.P. Morgan Markets Limited, J.P. Morgan Securities
Australia Limited, J.P. Morgan Securities (Asia Pacific) Limited, J.P. Morgan Securities Japan Co., Ltd
and J.P. Morgan Prime Nominees Limited and any additional entity notified to the Company from time
to time.
Transfer date
Settlement Date
03-Jan-2025
06-Jan-2025
07-Jan-2025
09-Jan-2025
13-Jan-2025
14-Jan-2025
15-Jan-2025
17-Jan-2025
21-Jan-2025
Holder of voting
rights
JPMS is the holder of the voting rights from the time at which it exercises its right to borrow.
Notwithstanding this, please note that the Company has the right to recall equivalent securities if it
wishes to exercise its voting rights in respect of the securities.
Are there any
restriction on voting Yes
rights
If yes, detail
JPMS will not be able to exercise voting rights in circumstances where the Company has recalled
equivalent securities from JPMS before the voting rights have been exercised. In these circumstances,
JPMS must return the securities to the Company and the Company holds the voting rights.
Scheduled return
date (if any)
N/A. There is no term to the loan of securities.
Does the borrower
have the right to
return early?
Yes.
If yes, detail
JPMS has the right to return all and any securities or equivalent securities early at any time.
Does the lender
have the right to
recall early?
Yes.
If yes, detail
The Company has the right to recall all or any equivalent securities on demand.
Will the securities be
Yes. Settlement of the loan will occur when JPMS returns equivalent securities to the Company. There
returned on
is no term to the loan of securities.
settlement?
If yes, detail any
exceptions
Statement
If requested by the company to whom the prescribed form must be given, or if requested by ASIC, a
copy of the agreement will be given to that company or ASIC.
Share your feedback
Discover